BACITRACIN- bacitracin zinc ointment 
Preferred Pharmaceuticals, Inc

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Bacitracin zinc 500 units ......First Aid Antibiotic

Help prevent infection in

  • minor cuts
  • scrapes
  • burns

If swallowed, get medical help or contact a Poison Control Center right away

Helps prevent infection in

  • Minor cuts
  • Scrapes
  • Burns

  • Clean affected area
  • apply small amount (equal to surface area of tip of finger) on area 1 to 3 times daily
  • may be covered with a sterile bandange

For external use only

Warnings
Allergy Alert:  do not use if allergic to any of the ingredients
Do Not Use:
  • In eyes      
  • On large parts of the body
Ask a doctor before use if you have:
  • deep or puncture wounds
  • animal bites
  • serious burns
When using this product:
  • do not use for more than 1 week
Stop us and ask doctor if:
  • condition lasts or gets worse
  • rash or other allergic reaction occurs

White Petralatum

Relabeled by Preferred Pharmaceuticals, Inc

Anaheim, CA 92807

image of bacitracin label

BACITRACIN 
bacitracin ointment
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68788-0191(NDC:0472-1105)
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BACITRACIN ZINC (BACITRACIN) BACITRACIN500 [USP'U]  in 1 g
Inactive Ingredients
Ingredient NameStrength
PETROLATUM 
Packaging
#Item CodePackage Description
1NDC:68788-0191-228 g in 1 TUBE
2NDC:68788-0191-114 g in 1 TUBE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333B12/03/201005/07/2013
Labeler - Preferred Pharmaceuticals, Inc (791119022)
Establishment
NameAddressID/FEIBusiness Operations
Preferred Pharmaceuticals, Inc791119022REPACK(68788-0191)

Revised: 05/2013
 
Preferred Pharmaceuticals, Inc